drugset / Trial / NCT01311882
A Study to Evaluate Next Day Effects of MK-4305 on Driving Performance (MK-4305-035 AM1)
RandomizedCrossoverDouble-blindTreatment
Summary
This is a study to evaluate next-day residual effects of MK-4305 on highway driving performance in healthy, non-elderly participants.
Timeline
- Start
- 2011-04
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Suvorexant | Small molecule | 20 mg | — |
| Subject | Suvorexant | Small molecule | 40 mg | — |
| Comparator | Zopiclone | Small molecule | 7.5 mg | — |